WHO approves Pfizer's Paxlovid but scolds company about price transparency on the COVID-19 pill

In recommending the use of Pfizer's COVID-19 oral antiviral, the WHO implored the company to make Paxlovid more accessible to the world.

Related Keywords

,Paxlovid ,Pfizer ,World Health Organization ,Covid 19 ,Medicines Patent Pool ,Unicef ,Gilead Sciences ,Veklury ,Fierce Pharma Homepage ,Pharma ,